Further research is needed to better characterize kratom’s mechanisms of liver injury and to inform clinical decision-making and public health policy.
Further research is needed to better characterize kratom’s mechanisms of liver injury and to inform clinical decision-making and public health policy.
These findings provide evidence-based guidance for treatment duration, realistic expectation-setting, and individualized prognosis determination in cannabis use disorder recovery.
The primary study outcomes were ROI ratios and net profits after 3 years in operation.
Evidence suggests that patients who lose a primary care physician experience higher emergency department use.
Nicotine vaping is likely to cause lung and oral cancers, a comprehensive review of more than 100 studies has concluded. According to the analysis, human and animal studies, as well as cell experiments looking at the effects of chemicals found in vape liquid, all point toward carcinogenicity. Those studies, published since 2017, record "increasing concern", the researchers report.
These papers call on state leaders to refocus on SMI and serious emotional disturbances (SED) treatment and recovery— and to renew their commitment to system changes in improving whole-person health.
Psychiatric pharmacists are advanced practice clinical pharmacists who specialize in mental health care. With an extensive knowledge of medication management, they are skilled at treating the whole patient. They strengthen the mental health team by working directly with patients and improving treatment outcomes.
AAPP is a member-driven organization, and we currently support several technologies that facilitate the free exchange of information among pharmacists and other health care professionals. To promote a safe, friendly and professional environment, we have documented acceptable behavior and use of data. Please take a moment to read the following terms of use and policies:
AAPP members have developed tools and toolkits for the benefit of fellow psychiatric pharmacists and to further the knowledge of other pharmacists and health care professionals. You are encouraged to share these to educate others and highlight the value of psychiatric pharmacists. For practice-related resources, explore the Employer Resource Center.
Learners who do not achieve a passing score on a post-activity assessment may take a remediation assessment and/or appeal assessment questions.
No summary available
What you need to know about Psychedelic Therapies: Safety and Legality of Psychedelic Compounds.
The CDC and White House Office of National Drug Control Policy (ONDCP) issued an advisory to notify the public about increasing reports detecting medetomidine in the illegal drug supply causing withdrawal syndrome. Medetomidine is used for sedation and analgesia in dogs but is not approved for human use. Medetomidine can cause sedation, bradycardia, and hypotension and stopping it after regular use may lead to severe withdrawal.
Fewer than half of outpatient facilities for substance use disorder accept Medicare, according to a new HHS report. But low reimbursement rates and difficulty finding mental health workers factor into clinics' ability to care for older adults who need behavioral health care, the report found.
No summary available
The mock exam is composed of 150 questions based on the content domains and knowledge statements included in the BPS content outline. Register today and practice, practice, practice!
The treatment of cannabis use disorder, special populations and co-occurring disorders as well as harm reduction strategies are also addressed in the toolkit.
As AI chatbots become more widely used, questions are emerging about how they may affect mental health.
The primary outcome was change in Fatigue Severity Scale (FSS) score.
Every 2 years (on the even year), the Resident and New Practitioner Committee conducts a survey of program directors to establish emerging trends in psychiatric pharmacy residency programs.
No summary available
No summary available
Expand availability to clozapine for those living with schizophrenia. Register now for the CURESZ Foundation Clozapine Panel!
Shadi Doroudgar, PharmD, APh, BCPS, BCGP, BCPP Assistant Dean of Enrollment Management Associate Professor